Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Open research · Psilocybin & psilocin

Trial pipeline

Track psilocybin trial phases, recruitment, sponsors and registry completion dates with country filters, source links, comparison and free data exports.

Free access · No subscription for research tools or data exports

Filter the development pipeline

Reset

9 trials match this view; 12 reported facilities; 12 have usable coordinates. Latest indexed registry check Nov 19, 2026 02:23 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.

Enrollment sum: 657 across 9 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.

Recorded study-start years

20211
20231
20242
20254
20271

Current indexed registry status

Recruiting5
Withdrawn2
Active, not recruiting1
Terminated1

Reported research conditions

Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.

Milestones to investigate

The table is ordered by reported primary completion date. Check whether the registry calls enrollment estimated or actual, when the record was last updated, and whether results have been published. Completion dates are not readout dates; no model-generated success probabilities are assigned.

For late-stage studies, choose PHASE3 above. For studies still underway, choose an exact recruitment status. Use sponsor and country filters to inspect a programme, then save records to compare their designs.

Matching trial records

9 matching registry records. Dates are registry milestones, not promised results announcements.
TrialSponsor and phaseStatusEnrollmentStart / primary completion / completionResearch workflow
A Randomized, Double-Blind Study of Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use

NCT05242029

Opioid Use Disorder
Johns Hopkins University

PHASE2

Withdrawn

Registry updated 2024-02-02

0

ACTUAL

2023-12
2024-02
2024-12
Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects

NCT06624137

OCD · Major Depressive Disorder (MDD) · Alcohol Use Disorder (AUD) · Healthy Volunteer · Migraine · PTSD · PTSD - Post Traumatic Stress Disorder · Addiction · Tobacco Use Disorder · Obsessive Compulsive Disorder (OCD) · Opioid Use Disorder
Yale University

Phase not reported

Terminated

Registry updated 2026-07-09

5

ACTUAL

2024-12-12
2026-06-14
2026-06-14
Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone Formulation

NCT04161066

Opioid Use Disorder
University of Wisconsin, Madison

PHASE1

Recruiting

Registry updated 2026-07-07

10

ESTIMATED

2021-01-13
2026-12
2026-12
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)

NCT06160284

Opioid Use Disorder
Yale University

PHASE1

Recruiting

Registry updated 2026-07-07

12

ESTIMATED

2025-05-28
2027-01
2027-01
Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder

NCT06810310

Opioid Use Disorder
University of Pennsylvania

PHASE2

Recruiting

Registry updated 2026-07-09

24

ESTIMATED

2025-12-22
2027-05-01
2027-05-01
A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?

NCT06786325

Opioid Use Disorder
Anna Rose Childress, Ph.D.

PHASE2

Active, not recruiting

Registry updated 2026-11-06

36

ESTIMATED

2025-10-07
2027-06
2027-10
Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial

NCT06067737

Opioid Use Disorder
Johns Hopkins University

PHASE2

Recruiting

Registry updated 2026-07-17

90

ESTIMATED

2024-02-08
2028-07
2029-05
Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial

NCT06005662

Opioid Use Disorder
Johns Hopkins University

PHASE2

Withdrawn

Registry updated 2026-02-23

0

ACTUAL

2027-04
2028-07
2028-07
A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone Treatment

NCT06796062

Opioid Use Disorder
NYU Langone Health

PHASE2

Recruiting

Registry updated 2026-01-23

480

ESTIMATED

2025-12-17
2029-02
2029-02

Reported research facilities

Connecticut Mental Health CenterHamden, Connecticut, United States · Coordinates available
Duke City Recovery ToolboxAlbuquerque, New Mexico, United States · Coordinates available
Johns Hopkins Center for Psychedelic and Consciousness ResearchBaltimore, Maryland, United States · Coordinates available
Johns Hopkins UniversityBaltimore, Maryland, United States · Coordinates available
NYU Langone HealthNew York, New York, United States · Coordinates available
StartCareBrooklyn, New York, United States · Coordinates available
University of New MexicoAlbuquerque, New Mexico, United States · Coordinates available
University of PennsylvaniaPhiladelphia, Pennsylvania, United States · Coordinates available
University of WisconsinMadison, Wisconsin, United States · Coordinates available
VIP Community Services, IncThe Bronx, New York, United States · Coordinates available
West Haven VA Medical CenterWest Haven, Connecticut, United States · Coordinates available
Yale UniversityNew Haven, Connecticut, United States · Coordinates available

This directory includes reported facilities with and without coordinates. For a country-filtered view, locations are labeled as selected-country sites or international sites of matching trials. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.